INITIATIVES OF THE EAHAD GLANZMANN WORKING GROUP

EHA Library, Roger E.G. Schutgens, 422103

THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RAS): A PROMISING THERAPY FOR CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT)

EHA Library, Ludovica Fucci, 422104

DISCLOSING IMMUNE THROMBOCYTOPENIA: A RETROSPECTIVE COHORT ANALYSIS IN CALI, COLOMBIA (2016-2021)

EHA Library, Monica Fernandes Pineda, 422105

EPTIFIBATIDE INDUCED THROMBOCYTOPENIA IN ACUTE CORONARY SYNDROME: A RETROSPECTIVE DATA REVIEW

EHA Library, Shehab Fareed Abdelgabber, 422106

A PHASE 1B STUDY TO EVALUATE THE SAFETY AND PRELIMINARY EFFICACY OF SOVLEPLENIB, A SYK INHIBITOR, IN ADULT SUBJECTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Waleed Ghanima, 422107

EFFECTS OF ORAL BRUTON TYROSINE KINASE INHIBITOR RILZABRUTINIB ON THE PLATELET VARIABILITY INDEX SCORE IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: PHASE 2 STUDY

EHA Library, Donald Arnold, 422108

EPIDEMIOLOGY, TREATMENT PATTERNS AND QUALITY OF LIFE IN PATIENTS WITH NEWLY DIAGNOSED ADULT IMMUNE THROMBOCYTOPENIA (ITP): RESULTS FROM THE PROSPECTIVE MULTICENTER GERMAN ITP REGISTRY (D.ITP)

EHA Library, Julia-Annabell Georgi, 422109

REAL-WORLD EXPERIENCE WITH FOSTAMATINIB IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: RESULTS OF AN OBSERVATIONAL STUDY (FORTE)

EHA Library, Drew Provan, 422110

THERAPY OF IMMUNE THROMBOCYTOPENIA WITH THROMBOPOIETIN RECEPTOR AGONISTS IN THE SECOND AND SUBSEQUENT LINES.

EHA Library, Maria Pankrashkina, 422111

MANAGING CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) WITH ELTROMBOPAG; A RETROSPECTIVE REAL-WORLD ANALYSIS

EHA Library, Mehmet Baysal, 422112

REAL WORLD DATA ON THROMBOTIC THROMBOCYTOPENIC PURPURA IN CROATIA FROM THE WORKING GROUP FOR BENIGN HEMATOLOGICAL DISEASES OF THE KROHEM

EHA Library, Drazen Pulanic, 422113

OUTCOMES OF COMBINATION THERAPY FOR PATIENTS WITH CHRONIC REFRACTORY ITP: INSIGHTS FROM A SINGLE-CENTRE EXPERIENCE

EHA Library, Lucy Kamuriwo, 422114

THROMBOCYTOPENIA IN HIV INFECTION

EHA Library, Chingiz Mabudzada, 422115

CYCLIC THROMBOCYTOPENIA: A CASE SERIES FROM MAYO CLINIC

EHA Library, Nadia Toumeh, 422116

CURRENT APPROACHES TO THE TREATMENT OF ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA: A COMPREHENSIVE REVIEW OF THERAPEUTIC STRATEGIES AND CONSIDERATIONS

EHA Library, Moazzam Shahzad, 422117

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA TREATED WITH AVATROMBOPAG IN THE UNITED STATES: REAL-AVA 2.0 INTERIM ANALYSIS RESULTS

EHA Library, Scott Kolodny, 422118

ROLE OF PLATELET TO LYMPHOCYTE RATIO (PLR) AS A PROGNOSTIC FACTOR IN IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, Claudia Pia Schifone, 422119

EXPRESSION OF BECLIN-1 AUTOPHAGY PROTEIN IN ITP PATIENTS

EHA Library, Fady Hennawy, 422120

ANTI-PHOPHATIDYL SERINE AND ANTI-PROTHROMBIN ANTIBODIES (APS/PT) INIMMUNE THROMBOCYTOPENIA: SPACE FOR A MISDIAGNOSED ANDUNDERSTIMATED FORM OF SECONDARY ITP?

EHA Library, Sofia Camerlo, 422121

COMPREHENSIVE CHARACTERIZATION OF HEMATOLOGICAL ALTERATIONS IN FAMILIAL SITOSTEROLEMIA

EHA Library, Miguel Oliveira, 422122

PREDICTION OF STEROID RESPONSE IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA BY EVALUATING CD20+ B CELLS IN THE BONE MARROW

EHA Library, Yosuke DOMON, 422123

DOES ADMINISTRATION OF INTRAVENOUS IMMUNOGLOBULIN IN COMBINATION WITH RITUXIMAB REDUCE ITS RESPONSE IN IMMUNE THROMBOCYTOPENIA?

EHA Library, Sylvain Audia, 422124

CHARACTERISTICS OF PATIENTS WITH CYCLIC THROMBOCYTOPENIA: AN INTERNATIONAL REGISTRY STUDY

EHA Library, Lisbeth Eischer, 422125

TREATMENT OF CRITICAL BLEEDS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW

EHA Library, Saifur Rahman Chowdhury, 422126

PREDICTION OF IMMUNE THROMBOCYTOPENIA PROGRESSIONBASED ON GLYCOCALICIN TEST DATA

EHA Library, Moldir Beshimbayeva, 422127

PHASE 4 STUDY RESULTS EVALUATING THE SAFETY, EFFICACY, AND TREATMENT SATISFACTION IN CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM

EHA Library, Scott Kolodny, 422128

SIALIC ACID LOSS IN PLATELETS: IMPLICATIONS IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

EHA Library, Yessenia Lizbeth Molina Cabrera, 422129

CD8+CD25+ TREGS AS A PREDICTOR FOR GLUCOCORTICOID SENSITIVITY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

EHA Library, Sara El-sayed, 422131

EVANS SYNDROME IN CROATIA – DATA FROM THE WORKING GROUP FOR BENIGN HEMATOLOGICAL DISEASES OF THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL DISEASES KROHEM

EHA Library, Zdravko Mitrovic, 422132

A MULTI-COHORT STUDY ON THE HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Paul Coppo, 422133

TREATMENT OUTCOMES OF TPO-RECEPTOR AGONISTS IN PATIENTS WITH STEROID-REFRACTORY IMMUNE THROMBOCYTOPENIA; CONDITIONS FOR DISCONTINUATION WITH SUSTAINED PLATELET RESPONSE

EHA Library, JAE HO YOON, 422134

SPLEEN MICROBIOTA DYSBIOSIS PLAY A ROLE IN RESPONSE TO SPLENECTOMY IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: A PROSPECTIVE COHORT STUDY

EHA Library, Jia Chen, 422135

FUNCTIONAL CHARACTERIZATION OF A NANOBODY BASED GPVI SPECIFIC PLATELET AGONIST

EHA Library, Minka Zivkovic, 422136

BASIC CHARACTERISTICS OF ADULT PATIENTS WITH PREVIOUSLY TREATED IMMUNE THROMBOCYTOPENIA ENROLLED IN LUNA 3 PHASE 3 PLACEBO-CONTROLLED STUDY OF RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR

EHA Library, David Kuter, 422137

REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA IN PREGNANCY: DISTRICT GENERAL HOSPITAL EXPERIENCE IN MANAGING CLINICAL AND BIO-PSYCHO-SOCIAL COMPLEXITIES RELATED TO THROMBOPOIETIN RECEPTOR AGONISTS

EHA Library, Diana Mihalca, 422138

LONG-TERM SAFETY OUTCOMES OF ELIGLUSTAT IN PATIENTS WITH GAUCHER DISEASE: PROSPECTIVE, MULTICENTER, OBSERVATIONAL, POST AUTHORIZATION SAFETY SUB-REGISTRY STUDY

EHA Library, Pilar Giraldo, 422139

STEROIDS VS ELTROMBOPAG FOR FIRST AND SECOND-LINE TREATMENT OF ADULT IMMUNE THROMBOCYTOPENIA

EHA Library, Carlos Martínez Murillo, 422140

TREATMENTS FOR IMMUNE THROMBOCYTOPENIA (ITP) PLACE A BURDEN ON PATIENTS AND IMPACT QUALITY OF LIFE (QOL): INSIGHTS FROM A SOCIAL MEDIA LISTENING EXERCISE

EHA Library, Caroline Kruse, 422142

THROMBOCYTOPENIA IN PREGNANCY : A DESCRIPTIVE STUDY AND MANAGEMENT OF GESTATIONAL THROMBOCYTOPENIA AND IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

EHA Library, Ines Ben Rekaya, 422143

SELECTION AND EFFICACY OF DIFFERENT TREATMENTS FOR ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: A CHINESE MONOCENTRIC RETROSPECTIVE STUDY

EHA Library, Jian Huang, 422144

THE ALTERNATIVE SPLICING OF LCK IN TREG INDUCTION IN IMMUNE THROMBOCYTOPENIA

EHA Library, Shaoqiu Leng, 422145

TREATMENT AND COMPLICATIONS OF PORTAL VEIN THROMBOSIS: HOW, HOW MUCH, AND FOR WHOM?

EHA Library, Mónica Fernández Pérez, 422146

ASSESSMENT OF THROMBIN GENERATION TEST USING ST-GENESIA® IN CARRIERS OF PROTHROMBIN G20210A MUTATION

EHA Library, Carlos Aguilar, 422147

GENETIC ASSOCIATION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI:RS7586970 VARIANT) WITH CIRCULATING TISSUE FACTOR PATHWAY INHIBITOR LEVELS AND ISCHEMIC CORONARY ARTERY DISEASE

EHA Library, Doha Abdelhamid, 422148

APPROACH TO THE TREATMENT OF SUPERFICIAL THROMBOPHLEBITIS IN PREGNANCY – DATA FROM A PHYSICIAN SURVEY

EHA Library, Sajida Kazi, 422149

CLINICAL CHARACTERISTICS AND OUTCOMES OF YOUNG PATIENTS WITH THROMBOTIC MICROANGIOPATHY AT AIN-SHAMS UNIVERSITY CHILDREN’S HOSPITAL

EHA Library, Sara Makkeyah, 422150

PECTORAL MUSCLE LOSS  IS ASSOCIATED WITH ELEVATED FIBRINOLYTIC SYSTEM COMPONENTS IN COVID-19

EHA Library, Taner Tan, 422151

PREVALENCE AND VENOUS THROMBOTIC RISK OF ARG67STOP POLYMORPHISM IN THE PROTEIN Z-DEPENDENT PROTEASE INHIBITOR

EHA Library, Nuria Bermejo-Vega, 422152

VON WILLEBRAND FACTOR (VWF) AS A BIOMARKER OF SEVERITY IN INFECTION: THE CASE OF THE COVID-19 DISEASE

EHA Library, Panagiota Tsiatsiou, 422153

PHLEGMASIA CERULEA DOLENS IN A PATIENT WITH MAY THURNER SYNDROME – A CASE REPORT

EHA Library, Joana Ribeiro, 422154

USAGE PATTERN OF ANTICOAGULANTS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES RECEIVING ANTICANCER THERAPIES IN EU4 + UK.

EHA Library, Magdalena Ruiz, 422155

ATYPICAL PRESENTATIONS OF PEDIATRIC ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Assaf Barg, 422156

A COMPARATIVE ANALYSIS OF CONCENTRATIONS OF DIRECT ORAL ANTICOAGULANTS USING TWO ANTI-XA REAGENTS: DOAC LEVELS IN PATIENTS PLASMA

EHA Library, Sun Hack Lee, 422157

NATURAL ANTICOAGULANTS AND COMPLETE BLOOD COUNT INDICES IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS

EHA Library, Ahmed Almenshawy, 422158

EFFICACY AND SAFETY OF RIVAROXABAN USE IN GREEK CHILDREN : A SINGLE REFERENCE CENTRE OBSERVATIONAL STUDY

EHA Library, AIKATERINI MICHALOPOULOU, 422159

EXPERT-LED CASE-BASED EDUCATION IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA INCREASES COMPETENCE IN IMPROVING LONG-TERM OUTCOMES

EHA Library, S Christy Rohani-Montez, 422160

CEREBRAL VEIN THROMBOSIS

EHA Library, Turki Alshuaibi, 422161

YOUNG AND HEALTHY, BUT NOT IMMUNE: A CASE OF THROMBOTIC THROMBOCYTOPENIC PURPURA

EHA Library, Pedro Lupi, 422162

HEMOSTASIS-MODULATING EFFECT OF TUMOR MICROENVIRONMENT FACTORS ON THE BLOOD CIRCULATORY BED OF ONCOHEMATOLOGICAL PATIENTS

EHA Library, Vira Barilka, 422163

DESCRIPTION OF A SERIES OF CASES WITH PROTEIN S DEFICIENCY IN THE HEALTH AREA OF TOLEDO (SPAIN).

EHA Library, Ana Camacho Valencia, 422164

INDIRECT EVALUATION OF VASCULAR AND PLATELET HEMOSTASIS IN PATIENTS WITH UNSTABLE ANGINA IN EMERGENCY SETTINGS

EHA Library, Yuliya Tyravska, 422165

STUDY OF THE DEVELOPMENT AND IMPLICATION OF NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN VASCULAR COMPLICATIONS OF LYSOSOMAL DISEASES.

EHA Library, Irene Serrano-Gonzalo, 422167

THROMBOSIS IN COVID-19 PATIENTS

EHA Library, Turki Alshuaibi, 422168

DESCRIPTIVE ANALYSIS OF A SERIES OF CASES OF HOMOZYGOUS CARRIERS OF THE 46C>T POLYMORPHISM IN THE FACTOR XII GENE.

EHA Library, Karla Susana Calzadilla Román, 422169

ACTIVITY OF BLOOD PLASMA MICROPARTICLES IN PATIENTS WITH LOWER EXTREMITY VASCULAR DISEASE

EHA Library, Olesia Matvienko, 422170

ASSESSMENT OF THROMBIN GENERATION TEST USING ST-GENESIA® IN WOMEN WITH EARLY RECURRENT MISCARRIAGE

EHA Library, Carlos Aguilar, 422171

HEREDITARY ANGIOEDEMA: THE OPTIMISATION OF MOLECULAR STUDIES IN DIFFERENTIAL DIAGNOSTICS

EHA Library, Ivo Barreiros, 422172

PATIENT INTERVIEW–BASED CONTENT VALIDATION OF THE MYELOFIBROSIS SYMPTOM ASSESSMENT FORM VERSION 4.0 (MFSAF V4.0)

EHA Library, Heather Gelhorn, 422175

PHYSICAL ACTIVITY IN RELATION TO SYMPTOM DEVELOPMENT AMONG PATIENTS WITH HEMATOLOGICAL CANCER DURING THEIR FIRST HALF YEAR AFTER DIAGNOSIS

EHA Library, Simone Oerlemans, 422176

MULTIPLE MYELOMA SYMPTOMS RELEVANT TO PATIENTS AND LINKED TO DISEASE PROGRESSION: A SYSTEMATIC LITERATURE REVIEW AND DELPHI PANEL

EHA Library, Martin Kortüm, 422177

QUALITY OF LIFE AFTER IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE IN CHINA: A CROSS-SECTIONAL, MULTI-CENTER SURVEY OF PATIENT REPORTED OUTCOME AND CAREGIVER REPORTED OUTCOME

EHA Library, JIA CHEN, 422178

THE EFFECTIVENESS OF SYNBIOTIC PREPARATION IN PATIENTS WITH NEWLY DIAGNOSED LYMPHOMAS

EHA Library, Mariia Voytko, 422179

BURDEN OF MULTIPLE MYELOMA IN WOMEN: COLOMBIA AND THE REGION OF THE AMERICAS, 2000-2019.

EHA Library, Claudia Sossa-Melo, 422180

A QUALITATIVE STUDY OF HEMATOLOGICAL CANCER PATIENTS’ HEALTH INFORMATION NEEDS IN KUWAIT

EHA Library, Fatima Khadadah, 422181

QUALITY OF LIFE AND CLINICAL OUTCOMES IN PATIENTS WITH POLYCYTHEMIA VERA (PV) RECEIVING RUXOLITINIB TREATMENT IN A REAL-WORLD SETTING

EHA Library, Tatyana Ionova, 422183

UNDERSTANDING THE PATIENT EXPERIENCE IN NON-HODGKIN’S LYMPHOMA; A QUALITATIVE PATIENT INTERVIEW STUDY

EHA Library, Sophie Van Tomme, 422184

COMPARATIVE EVALUATION OF QUALITY OF LIFE IN HEMOPHILIA A PATIENTS UNDER PROPHYLAXIS: A 4-YEAR PERSPECTIVE

EHA Library, Nikolaos Kotsiou, 422185

CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE CONSOLIDATION AFTER UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION CAUSED NO SIGNIFICANT PATIENT-REPORTED SHORTNESS OF BREATH: FINDINGS FROM THE CONPET STUDY

EHA Library, Lene Kongsgaard Nielsen, 422186

IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE  SYMPTOM BURDEN SCALE (ISBUS): PROTOCOL FOR THE DEVELOPMENT OF A NOVEL STANDARDIZED PATIENT REPORTED OUTCOME MEASURE

EHA Library, Philip Powell, 422187

LEUKEMIA BURDEN IN THE COLOMBIAN POPULATION AND ITS CONTEXT IN THE REGION OF THE AMERICAS, 2000-2019.

EHA Library, Claudia Sossa-Melo, 422188

DEVELOPMENT OF NUTRITIONAL SCREENING FOR ONCOLOGY OUTPATIENTS: NSOO-2024

EHA Library, Celso Arrais-Rodrigues, 422189

EFFECTS OF AN EXERCISE THERAPY ON PHYSICAL FUNCTIONING AND QUALITY OF LIFE DURING ADULT UMBILICAL CORD BLOOD TRANSPLANTATION: A RANDOMIZED CONTROLLED TRIAL

EHA Library, Chengzhen Jia, 422190

BURNOUT AMONG PALLIATIVE CARE DOCTORS IN ONCO-HEMATOLOGY

EHA Library, rihab ben sghaier, 422191

STUDY ON THE EFFECT OF GUIZHI FULING DECOCTION ON CHEMOTHERAPY-RELATED PERIPHERAL NEUROPATHY BY REGULATING METTL3/LET-7/NGF AXIS

EHA Library, xing cui, 422192

NURSING CARE OF A LYMPHOMA PATIENT WITH COVID-19 INFECTION UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH CAR-T TREATMENT

EHA Library, Liu Tingting, 422193

CLINICAL HEMATOLOGY CAREGIVING STAFF: WHAT IMPACT ON PERSONAL AND PROFESSIONAL LIFE?

EHA Library, kenza Darkaoui, 422194

FINANCIAL BURDEN OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA IN NORTH MACEDONIA IN THE ERA OF NOVEL IMMUNOTHERAPIES

EHA Library, Nevenka Ridova, 422195

SUSTAINED COST-EFFECTIVENESS OF BREXUCABTAGENE AUTOLEUCEL FOR THE TREATMENT OF RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS AGED 26 YEARS OR OLDER IN ITALY

EHA Library, Monia Marchetti, 422196

THE INFLUENCE OF SOCIOECONOMIC FACTORS ON MORTALITY IN ACUTE MYELOID LEUKEMIA - AN INDIAN PERSPECTIVE

EHA Library, Priscilla Nethala, 422197

HEALTH ECONOMIC IMPACT OF SECOND-LINE INTERVENTIONS OF DIFFUSE LARGE B-CELL LYMPHOMA FOR TRANSPLANT-INELIGIBLE PATIENTS IN GERMANY

EHA Library, Melina Sophie Kurte, 422198

INNOVATIVE LABEL-FREE LYMPHOMA DIAGNOSIS USING INFRARED SPECTROSCOPY AND MACHINE LEARNING ON TISSUE SECTIONS

EHA Library, Sander De Bruyne, 422199

COMMUNITY: A NOVEL R-TOOL FOR DIFFERENTIAL COMMUNICATION ANALYSIS IN HUMAN BONE MARROW SCRNASEQ DATA OF AML PATIENTS IN A CASE-CONTROL DESIGN

EHA Library, Muhammet Celik, 422200

RISK FACTORS FOR SURVIVAL AND A PREDICTIVE MODEL OF INFUSION-RELATED REACTION IN B-CELL LYMPHOMA PATIENTS RECEIVING OBINUTUZUMAB

EHA Library, Shijie Li, 422201

TOWARDS AUTOMATED CYTOMORPHOLOGY ANALYSIS IN BONE MARROW SAMPLES: ARTIFICIAL INTELLIGENCE CAN INCREASE THE PRECISION OF BLAST COUNT

EHA Library, Miguel Gomez, 422202

AI-BASED AUTOMATION OF BONE MARROW PLASMA CELL QUANTIFICATION: IMPLICATIONS OF REDUCING VARIABILITY FOR MULTIPLE MYELOMA DIAGNOSIS

EHA Library, Ana Mendoza, 422203

PHASE 3 STUDY RESULTS OF ISATUXIMAB, BORTEZOMIB, LENALIDOMIDE, AND DEXAMETHASONE (ISA-VRD) VERSUS VRD FOR TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (IMROZ)

EHA Library, Thierry Facon, 422204

THE LANDSCAPE OF TP53 MUTATIONS AND THEIR PROGNOSTIC IMPACT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Consuelo Bertossi, 422205

FIRST RESULTS OF THE APOLLO TRIAL: A RANDOMIZED PHASE III STUDY TO COMPARE ATO COMBINED WITH ATRA VERSUS STANDARD AIDA REGIMEN FOR PATIENTS WITH NEWLY DIAGNOSED, HIGH-RISK ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Uwe Platzbecker, 422206

ASCIMINIB (ASC) PROVIDES SUPERIOR EFFICACY AND EXCELLENT SAFETY AND TOLERABILITY VS TYROSINE KINASE INHIBITORS (TKI) IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) IN THE PIVOTAL ASC4FIRST STUDY

EHA Library, Andreas Hochhaus, 422207

ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA

EHA Library, Ali Taher, 422208